| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |